Express scripts manages payments between pharmacy prescription plans and insurance companies, as well as helping select name-brand versus generic drugs. In this video, Fool analyst Jim Mueller explains how the expiration of several big pharma drugs could open up a big opportunity for Express scripts.
Do lower costs = profits for your portfolio?
In 2011, a massive shift began. With the first of the baby-boomer generation reaching Medicare age, America's health care landscape was forever changed. Combine the aging population with the impact of Obamacare, and the need for innovative solutions for skyrocketing health care costs is as clear as ever. Express scripts is part of that solution, and in this brand new�premium report on the company, we clearly lay out the opportunity in front of this misunderstood stock. Claim your copy by clicking here now.
No comments:
Post a Comment